Chemical Company of Malaysia Bhd’s (CCM) newly acquired 73.8%-owned subsidiary, Duopharma Biotech Bhd, has been awarded a RM9.5 million contract by the Health Ministry to supply anti-retroviral drugs SLN30 and SLN40 tablets, to treat HIV/AIDS patients, to all government hospitals for two years starting 2006.
